Samphire Neuroscience Raises $5M Seed Funding to Revolutionize Women's Health with Brain-Based Innovation

We are thrilled to announce that Samphire Neuroscience has successfully raised £5,000,000 in our latest funding round, marking a significant milestone in our mission to transform women's health through brain-based innovation. This impressive capital infusion empowers us to accelerate the development of groundbreaking neurotechnologies designed with women’s unique needs in mind. With over 30 years of research and clinical expertise underpinning our work, Samphire Neuroscience stands at the forefront of combining advanced technology, elegant design, and functionality, ensuring that women everywhere have access to medical-grade solutions that empower them to take control of their health without compromising on their lifestyle. This funding will further our ongoing efforts to expand the reach and impact of Nettle, the world’s first brain-stimulating headband specifically designed to alleviate PMS and period pain symptoms in the comfort of one’s home. Already available in the UK and across the EU, Nettle is now undergoing clinical trials in populations affected by PMDD and endometriosis—an essential step towards delivering more targeted relief and improved quality of life for millions of women. In addition, we will be investing in our neuroscience-backed cycle tracking technology through the Samphire app, available on the Apple App Store and Google Play, to refine and expand features that provide personalized insights and empower women with better understanding of their bodies. Looking ahead, this new funding will enable us to continue developing innovative neurotechnologies, forge new clinical partnerships, and build upon our proven legacy of turning cutting‐edge science into effective, user-friendly solutions. We are excited to embrace this new chapter and remain committed to our vision—a world where every woman has access to transformative, technology-driven healthcare solutions.